Form D · Biotechnology
Ampel, LLC
Charlottesville, VA · CIK 0001842853
Offering snapshot reported Jul 6, 2023 · SEC filing
- Reported sold
- $1.8M Offering amount: $5M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Apr 28, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 6, 2023 | Initial | $1,800,000 | No comparison | 5 | SEC filing |
| Dec 13, 2022 | Initial | $1,110,000 | No comparison | 3 | SEC filing |
| Jun 15, 2021 | Initial | $350,000 | No comparison | Not reported | SEC filing |
| Feb 10, 2021 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Jan 29, 2021 | Initial | $1,030,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-486026
Source: Form D, filed Jul 6, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Amrie Grammer | Executive |
| Peter Lipsky | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
250 West Main Street Suite 300
Charlottesville, VA, 22902
Charlottesville, VA, 22902